Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Spironolactone, an antagonist of aldosterone, initially used as a potassium-sparing diuretic, was subsequently shown to be a very effective adjunctive agent in the treatment of patients with heart failure with reduced ejection fraction, by halting the disease progression, with significant beneficial...

Descripción completa

Detalles Bibliográficos
Autores principales: Manolis, Antonis A, Manolis, Theodora A, Melita, Helen, Manolis, Antonis S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941679/
https://www.ncbi.nlm.nih.gov/pubmed/31920323
http://dx.doi.org/10.2147/VHRM.S210150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941679/
https://www.ncbi.nlm.nih.gov/pubmed/31920323
http://dx.doi.org/10.2147/VHRM.S210150

Ejemplares similares